INSIDER

As GLP-1 medications such as Ozempic, Mounjaro and Wegovy rise in popularity, so do concerns over their side effects.

West Virginia patients are left in limbo over changing insurance coverage of obesity medications

Read full article: West Virginia patients are left in limbo over changing insurance coverage of obesity medications

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients because of the cost.

No description available

FDA says knockoff versions of Lilly obesity drug must come off the market

Read full article: FDA says knockoff versions of Lilly obesity drug must come off the market

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

No description available

Use of Wegovy and other weight-loss drugs soars among kids and young adults

Read full article: Use of Wegovy and other weight-loss drugs soars among kids and young adults

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.

Go to the KSAT homepage

GLP-1

San Antonio doctor addresses concerns over GLP-1 medications

West Virginia patients are left in limbo over changing insurance coverage of obesity medications

FDA says knockoff versions of Lilly obesity drug must come off the market

Use of Wegovy and other weight-loss drugs soars among kids and young adults